Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[US - IDUS - EUS for diagnosis of biliary tract neoplasms].
Hijioka S, Ikari T, Kamei A, Takano K, Asahara S, Fujita R. Hijioka S, et al. Among authors: ikari t. Nihon Rinsho. 2006 Jan;64 Suppl 1:393-7. Nihon Rinsho. 2006. PMID: 16457290 Review. Japanese. No abstract available.
[Diagnosis of pancreatic cystic tumor].
Ohashi K, Ikari T, Kamei A. Ohashi K, et al. Among authors: ikari t. Nihon Naika Gakkai Zasshi. 1992 Dec 10;81(12):1966-70. Nihon Naika Gakkai Zasshi. 1992. PMID: 1289448 Japanese. No abstract available.
[A case of diffuse type of hepatocellular carcinoma with tumor thrombosis of inferior vena cava (Vv3) and main trunk of portal vein (Vp4), showing marked response to transcatheter arterial chemoembolization with degradable starch microspheres (DSM-TACE)].
Asahara S, Ikari T, Kamei A, Sato E, Takano K, Fujita N, Shimizu M, Fujita R. Asahara S, et al. Among authors: ikari t. Nihon Shokakibyo Gakkai Zasshi. 2004 Dec;101(12):1332-9. Nihon Shokakibyo Gakkai Zasshi. 2004. PMID: 15651397 Japanese. No abstract available.
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study).
Ozaka M, Matsumura Y, Ishii H, Omuro Y, Itoi T, Mouri H, Hanada K, Kimura Y, Maetani I, Okabe Y, Tani M, Ikeda T, Hijioka S, Watanabe R, Ohoka S, Hirose Y, Suyama M, Egawa N, Sofuni A, Ikari T, Nakajima T. Ozaka M, et al. Among authors: ikari t. Cancer Chemother Pharmacol. 2012 May;69(5):1197-204. doi: 10.1007/s00280-012-1822-1. Epub 2012 Jan 17. Cancer Chemother Pharmacol. 2012. PMID: 22249272 Clinical Trial.
113 results